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Summary
Clonal deletion of thymocytes expressing potentially self-reactive T cell receptors (TCRs) occurs
during thymocyte ontogeny. Mice deficient for CD4 expression provide a unique model system
to study the contribution of the CD4 molecule in negative selection of T cells reactive against
the major histocompatibility complex class II-associated retroviral self-superantigen, Mls-la. In
the presence of Mls-1a determinants, mature CD8+ T cells expressing V06, 8.1, and 9 were
deleted in CD4-deficient mice, thus demonstrating that TCR affinity for Mls-1a is sufficient
for deletion and that a signal through CD4 was not required. However, in instances where the
TCR affinity for Mls-1a is low, as in the case of V(37+ T cells, CD4 expression was required
for clonal deletion. These results demonstrate that for Mls-la-mediated clonal deletion of T cells,
the requirement for the accessory or coreceptor function of CD4 depends on the affinity ofthe TCR.
O
ne mechanism by which self-tolerance is maintained is
through clonal deletion ofT cells expressing self-reactive
TCRs during thymocyte ontogeny (1) . The nature of the
tolerizing signal delivered to the developing thymocyte, how-
ever, has not yet been characterized. In addition, the contri-
bution of other cell surface molecules, for instance, CD4,
to tolerance induction is still controversial.
Recently, it has been demonstrated that Mls-1a deter-
minants are encoded by an endogenous mouse mammary
tumor virus, Mtv-7, integrated on chromosome 1 (2, 3) . T
cells expressing V06, 7, 8.1, and 9 are deleted during thymic
differentiation in Mls-11 strains of mice (4). Mls-la stimula-
tion in vitro of T cells or clonal deletion of thymocytes re-
quires the presence of MHC class II molecules, and there is
a hierarchy for MHC class II presentation ofMls-la; namely,
H-2k, H-2d > H-2b >> H-29, with I-E molecules being
better presenters than I-A molecules (4).
Mice rendered CD4 deficient by gene targeting (5) pro-
vide a unique system in which to study the requirement for
CD4 in negative selection of CD8+ T cells mediated by self-
superantigens. TCR V/3 expression was examined in C134-
deficient mice (CD4 - I - ) bred into Mls-1a and Mlsb back-
grounds. Vj36+, 8.1+, and 9+ T cells were deleted in
CD4 - I - Mls-la mice in I-E+ haplotypes. However, V07+
T cells were not deleted in CD4 -1- Mls-11 mice.
Miceand Mtv,7Analysis.
￿
B10.BR, BALRK, CBA/J, and DBA/2
strains of mice were purchased from The Jackson Laboratory
(Bar Harbor, ME). Mice homozygous for the CD4 mutation
(CD4- /- ) have been described previously (5). The breeding
strategy to obtain CD4 -/ - Mls-11 mice was as follows: CD4 het-
erozygous (CD4+/-) F, mice were obtained from crosses between
female DBA/2 (H-2d, Mls-1'), CBA/J (H-2', Mls-1'), or B10.BR
(H-2', Mlsb), and male CD4-/- H-2b Mlsb animals. The CD4+/-
F, progeny from each pair were mated, and pups from the FZ
generation were typed for CD4 expression and H-2 haplotype by
immunofluorescence. Mice were typed for Mls-1' by Southern blot
analysis for Mtv-7 integration, which is determined by the pres-
ence of an 11.7-kb band in blots ofEcoRI-digested genomic DNA
probed with an MMTV env probe (6, 7, and data not shown).
In Vitro Culture.
￿
Spleen cell responders (2 x 106) from mice
aged 6-12 wk were cocultured with 5 x 106 antiThy-1 and
complement-depleted and irradiated (1,000 bad) splenic stimulator
cells in 2 ml ofIMDM supplemented with 10% FCS, c-glutamine,
2-ME, antibiotics, and 10% rat spleen Con A supernatant as a source
of IL2. In experiment 2, responder cells (2 x 106) were stimu-
lated with 2.5 hg/ml Con A (Pharmacia, Uppsala, Sweden) in
medium lacking IL-2. On day 3, responding T cell blasts were iso-
lated on a Ficoll density gradient and cultured for another 2 d in
the presence ofIL-2, after which the cells were harvested and stained
for CD8 and TCR V(3 expression.
Immunofuorescence.
￿
Blood samples (200 pl) were collected in
heparinized capillary tubes, washed once in immunofluorescence
staining buffer (PBS, 4% FCS, 0.1% NaN3), and incubated with
the following anti-H-2 culture supernatants obtained from Amer-
ican Type Culture Collection (Rockville, MD): B8-24 (anti-H-2b)
(TIB 139), 34-2-12 (anti-H-2') (HB87), and 11-4-1 (anti-H-21)
(TIB 95), followed by FITC-conjugated goat anti-mouse antibodies
(Southern Biotechnology Associates, Inc., Birmingham, AL). For
CD4 analysis, blood samples were stained with PE-conjugated anti-
CD4 (Becton Dickinson & Co., Mountain View, CA). For TCR
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used: 44-22-1(antiV#6) (8), TR31(antiV07) (9), KJ16 (antiVO8.1,
8.2) (10), and B20.6 (antiV02) (11). The following mouse mAbs
were used: F23.2 (antiVO8 .2) (12) and MR10-2 (antiV09) (13).
Single cell suspensions ofthymocytes and mesenteric lymph nodes
from 6-8-wk-old mice were resuspended in staining buffer and in-
cubated with appropriate antiTCR VO culture supernatants,
washed, and labeled with PE-conjugated goat anti-rat Ig or FITC-
conjugated goat anti-mouse Ig (Southern Biotechnology Associates,
Inc.). Lymph node samples were incubated with 1 lAg of rat IgG
(Sigma Chemical Co., St. Louis, MO) to block remaining anti-rat
Ig sites, and cells were then double stained with anti-CD8 biotin
(Becton Dickinson & Co.) followed by Streptavidin-RED613 (Gibco
Laboratories, Grand Island, NY). T cell blasts were stained as de-
scribed for lymph node samples. Samples were analyzed using a
FACScan® (Becton Dickinson & Co.). The percentage of V08.1'
T cells was calculated by subtracting the percentage of V,Q8.2+
cells from the percentage of Va8.1+ + V08.2+ cells. Mean values
of TCR V/3 expression were statistically compared between Mls-1'
and Mlsb mice within the same H-2 haplotype using an unpaired
Student's t test. Probability values, p <0.05, were taken to be sig-
nificantly different.
Results and Discussion
To assess the requirement for CD4 expression in the Mls-
1a-mediated deletion of CD8+ T cells bearing V06, 7, 8.1,
and 9, the CD4 mutation was bred into different Mls and
H-2 backgrounds, as described in Materials and Methods.
The presence of Mls-1a was determined by Southern blot
analysis for Mtv-7 integration (data not shown). We first de-
termined whether the lack of CD4 expression during on-
togeny would adversely affect the development of Mls-1a-
reactive T cells in CD4 deficient (CD4- I- ) Mlsb (Mtv-7- )
mice. As previously reported, CD4- I- mice have a large pe-
ripheral TCR a/a+ CD8+ T cell population and a smaller
TCR ci/a+ CD4 - CD8 - population (5). CD8+ peripheral
Mice were typed for CD4, H-2, and Mls-la as described in Materials and Methods. Mesenteric lymph node cell suspensions from mice aged 6-8
wk were stained with appropriate anti-TCR VQ mAbs and anti-CD8, and analyzed by flow cytometry. Results are expressed as mean percent of
Vli+ CD8+ T cells ± SEM. Underlined values are not significantly different from one another.
At least three mice per group were analyzed.
t Staining for V02, which is not Mls-la reactive, is also included.
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T cells expressing Vf6, 7, 8, 1, and 9 were present in the lymph
nodes of CD4 -1- Mlsb H-2k or H-2d mice at levels similar
to CD4+' - Mlsb littermates or BALB.K (Mlsb, H-2k) mice
(Table 1 and Fig. 1) .
After in vitro Mls-1a stimulation, CD8+ T cell blasts
from CD4- I- Mlsb mice were enriched for V06 and 8.1 ex-
pression, as were CD8+ T blasts from control BALB.K mice
(Table 2). CD8+ T cells expressing V07+ TCRs were
poorly enriched in anti-Mls-1' cultures from both the
CD4 -1- Mlsb or control BALB.K mice, which is in agree-
ment with previous data showing that V07+ T cells are the
least Mls-1a reactive in vitro (14) . V09+ T cells were also
not significantly enriched in these cultures, and this may be
due to the strain combination used in this experiment. There-
fore, the lack of CD4 expression during thymic ontogeny
in CD4 -1- Mlsb mice did not affect the development of T
cells expressing Mls-1'-reactive V)(3s or in vitro reactivity
against Mls-la determinants.
Spleen cells from CD4 - I- Mls-1a H-2d or H-2k mice were
tolerant against Mls-1a as judged by low cell recovery and
lack of enrichment for V#6, 7, 8.1, or 9 CD8+ T cells after
a 5-d in vitro Mls-1a stimulation (Table 2, and data not
shown). Lymph node cells from CD4-- Mls-1a mice were
analyzed for expression of Mls-1a-associated V/3s in order to
determine if clonal deletion was the mechanism of tolerance
against Mls-1a (Table 1, and Fig. 1). CD8+ V06+ T cells
were significantly reduced in CD4 -1- Mls-1a H-2d and
H-2k mice when compared with their CD4 -1- Mlsb litter-
mates (p <0.05). V06+ T cells were also not present in the
CD4 - CD8- compartment of CD4-1- Mls-la mice (data
not shown). CD8+ T cells bearing V08.1 and 9 were also
reduced in CD4-I- Mls-1a H-2d mice to the same extent as
in CD4+ Mls-1' H-2d littermates and CBA/J (H-2k, Mls-
1a) control mice. These results demonstrate that in the ab-
sence of CD4 expression, CD8+ T cells bearing Va6, 8.1,
and 9 can be deleted by Mls-la determinants.
Table 1. TCR V,B Expression on CD8+ Lymph Node T Cellsfrom Control and CD4-l- Mice
Percent of CD8+ lymph node cells expressing:
Mouse" Mls H-2 I-E V/36 V07 V08.1 V09 V#2t
BALB.K b k + 11.6 ± 1 .0 3.2 ± 0.5 15.8 ± 1.7 2.1 ± 0.3 6.7 t 2.0
CBA/J a k + 0.1 ± 0.0 0.9 ± 0.5 5.5 ± 1.2 0.2 ± 0.1 16.5 ± 1.2
CD4+/- b d + 12.1 ± 0.3 4.0 ± 1.8 11 .4 ± 3.3 3.1 ± 0.9 7.7 ± 1.4
CD4+/- a d + 0.6 ± 0.1 1.3 ± 0.3 3.3 ± 0.5 0.6 ± 0.3 8.7 ± 0.7
CD4-/- b d + 10.6 ± 0.7 5.0 . ± 1.6 9.2 ± 1.6 2.0 ± 0.1 6.3 ± 1.1
CD4-/- a d + 1 .4 ± 0.2 2.9 ± 0.5 5 .5 ± 0.1 0.9 ± 0.1 6.6 ± 0.5
CD4 -/- b k + 8.9 ± 2.0 4.5 ± 0.6 ND ND 7.0 ± 1 .0
CD4 - /- a k + 1 .4 ± 0.2 3.2 ± 0.4 ND ND 9.9 ± 1 .0CD4 -/-
H-2d Mls°
CD8
T cells expressing V07 were not significantly reduced in
the lymph nodes of CD4-1- Mls-1a H-2d or H-2k mice as
compared with CD4` - Mls-1a H-2d or H-2k littermates,
or CBA/J mice, thus demonstrating that CD4 expression
is required for deletion of V07-bearing T cells (Table 1, and
data not shown). Although mice heterozygous for the CD4
mutation (CD4+/ -) have a slightly reduced intensity of sur-
face CD4 staining (5), Va7+ T cells were deleted in
CD4+/- Mls-la H-2d mice to the same extent as in CBA/J
mice (Table 1). Therefore, a reduction in CD4 surface inten-
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Figure 1.
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V/36 expression on CD8' T cells
from lymph nodes of CD4-/- mice. Cell sus-
pensions ofmesenteric lymphnodesfrom 6-8-
wk-old CD4-/- H-2d Mlsb and Mls-1a mice
were double stained forV06 andCD8expres-
sion, as described in Materials and Methods.
sity on T cells does not adversely affect deletion of V07+
T cells.
We next investigated whether deletion of V06+ T cells
could be detected in the thymus of CD4-1- Mls-1a mice.
In Mls-1a mouse strains, T cells expressing MIS-1a-reactive
Vos are present among the TCR° immature thymocyte
population, but are markedly reduced in the mature TCRh'
thymocyte population (1) . As summarized in Table 3, the
V06h` population of thymocytes was present in CD4-1-
Mlsb and in control BALB.K (Mlsb, H-2k) mice. However,
Spleen cell responders (2 x 106) from mice aged 6-12 wk were stimulated as described (Materials and Methods) and double stained with anti-V(3
mAb and CD8.
' NT, not tested.
t CBA/J stimulators are H-2k, Mls-1°.
Table 2. TCR V,Q Expression on CD8+ T Cell Blasts after In Vitro Mls-1° Stimulation
Percent of CD8+ T cell blasts
Exp. Responder Stimulator V06 V08.1 V08.2 V07 V09
1 BALB.K BALB.K 7.1 NT" NT NT NT
H-2k, Mlsb CBA/Jt 43.0 14.6 3.3 NT NT
CD4-/- BALB.K 7.7 9.7 14.1 NT NT
H-2k, Mlsb CBA/J 41.5 17.0 7.6 NT NT
CD4-'- BALB.K 2.9 NT NT NT NT
H-2k, Mls-1a CBA/J 2.1 5.6 14.4 NT NT
2 BALB.K Con A 13.1 18.4 16.2 10.2 3.3
BALB.K 16.5 NT NT NT NT
CBA/J 66.0 17.2 3.7 15 .0 2.4
CD4-/- Con A 12.4 11.4 19.2 5.0 3.1
H-2k, Mlsb BALB.K 10.8 10.9 17.0 6.8 3.5
CBA/J 64.0 11 .1 13.3 2.8 1.5
CD4-'- Con A 1.1 0.3 27.4 4.0 1.3
H-2k, Mls-1' BALB.K 1.4 3.8 20.3 3.9 NT
CBA/J 0.9 7.9 16.0 2.8 1.3Single cell suspensions of thymocytes from 6-8-wk-old mice were stained for V06, V07, and V,32 expression. Samples were analyzed on a FACScanO
and the percentage of thymocytes with high-intensity TCR V(3 expression was determined. Results are expressed as mean percent of Vohigh thymo-
cytes ± SEM, and the data are compiled from at least three animals per group. It should be noted that the percentages of TCR a/ohigh thymocytes
were similar in all mice tested.
the V06h' population was greatly reduced in thymus samples
from CD4 -/ - Mls-1a and control DBA/2 (Mls-1a, H-2d)
animals, thus demonstrating that V06-bearing T cells in
CD4 -i - Mls-1a mice were deleted in the thymus. While
Valhi thymocytes were reduced in DBA/2 thymocytes, they
were not reduced in CD4 - / - Mls-1a mice. Control staining
for V02+ T cells revealed that the mature population of
Valhi cells remained intact.
In vitro and in vivo studies have shown that Va7+ T cells
are the least reactive of all M1s-la-reactive Vos described to
date (14). In addition, the degree of reduction of V07+ T
cells in CD4+ Mls-1a mouse strains is not as drastic as that
of Va6+ T cells (9) . The data demonstrating that CD4 ex-
pression is required for deletion of V07-expressing T cells
are consistent with these previous findings and supports a
model in which Va7 has low affinity for Mls-la.
Reactivity against MHC class II-associated self-super-
antigens is more readily demonstrated with CD4+ T cells
expressing appropriate Vos, however, both mature CD4+
and CD8+ T cells expressing these Vos are deleted during
thymic development (15). A contribution of CD4 in dele-
tion mediated by MHC class II-associated self-superantigens
was inferred from studies in which anti-CD4 treatment was
able to prevent the deletion of CD8+ T cells bearing self-
superantigen-reactive V(3s (16, 17) . Therefore, it was postu-
lated that CD8+ T cells expressing self-superantigen-reactive
Vls were targeted for deletion as a result of CD4 expression
at the double-positive stage ofthymocyte development. How-
ever, it has been subsequently demonstrated that CD8+ T
We thank Dr. H. Acha-Orbea for providing the MMTV probe, Juliet Sheldon for flow cytometry advice,
and Drs. K. Kishihara and M. Schilham for critical reading of the manuscript.
This work was supported by grants from the Medical Research Council and National Cancer Institute
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cells from Mlsb mice are enriched for Va6, 8.1, and 9 ex-
pression after in vitro and in vivo Mls-la stimulation (18-
20), and that the in vitro anti-Mls-1a response of CD8+
V06+ T cells is MHC class II dependent (21). Our results
now demonstrate that CD4 expression is not absolutely re-
quired for Mls-1a-mediated clonal deletion of CD8+ V06+
T cells. However, the avidity required for clonal deletion of
Mls-1a-reactive TCRs may be attained through the interac-
tion of CD8 with MHC class I in the thymus. To address
this, experiments on clonal deletion in CD4/8-deficient mice
are currently underway.
In summary, CD8+ T cells expressing Va6, 8.1, and 9
TCRs are deleted from the periphery of CD4 - / - Mls-1a
mice. Analysis of V(3 expression on thymocytes has revealed
that deletion of Va6+ T cells can be detected in the thymus
of CD4-~- Mls-1a mice. Thus, deletion of T cells with high
affinity for Mls-1a determinants can occur in the absence of
a signal through CD4. Va7+ T cells were not deleted from
the periphery or the thymus in CD4- ~- Mls-1a mice.
Therefore, there is a differential requirement for CD4 expres-
sion in clonal deletion such that CD4 expression is required
for deletion when TCR affinity is reduced. There is evidence
that T cell recognition of superantigens is different from rec-
ognition of nominal peptide antigen in the groove of MHC
class II (22, 23) . Whether or not the finding that CD4
expression is differentially required for Mls-1a self-super-
antigen-mediated deletion ofT cellscan be extended to dele-
tion of T cells mediated by self-peptides presented in the groove
of MHC class II requires further study.
Table 3. TCR V,6''O Expression on Thymoctyes from CD4- '- Mice
Percent of Vo high-intensity thymocytes
Mice Mls H-2 V/36 V/37 V02
BALB.K b k 1 .1±0.1 0.7±0.1 0.6±0.1
DBA/2 a d 0.4 ± 0.1 0.2 ± 0.0 0.5 ± 0.0
CD4-/- b k 1.6±0.3 0.6±0.1 0.9±0.2
CD4- '- a k 0.4 ± 0.1 0.4 ± 0.1 0.9 ± 0 .3
CD4- / - a d 0.3±0.1 0.4±0.2 0.7±0.4References
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